Literature DB >> 1436122

Inhibitory and excitatory muscarinic receptors modulating the release of acetylcholine from the postganglionic parasympathetic neuron of the chicken heart.

G Brehm1, R Lindmar, K Löffelholz.   

Abstract

The effects of muscarinic receptor antagonists on ACh release were studied in the absence or presence of cholinesterase (ChE) inhibition using the isolated perfused chicken heart. Presynaptic inhibitory muscarinic autoreceptor were characterized by determining the potency of various antagonists to enhance [3H]-ACh release evoked by field stimulation (3 Hz, 1 min). The order of potencies was: (+/-)-telenzepine > atropine > 4-DAMP > silahexocyclium > pirenzepine > hexahydro-siladifenid-ol > AF-DX 116. The comparison with known pA2 values for M1-, M2- and M3-receptors revealed that the presynaptic autoreceptor meets the criteria of an M1-receptor. Basal, not electrically evoked overflow of unlabelled ACh into the perfusate was caused by 'leakage' release (non-exocytotic), as it was independent of extracellular Ca2+. Muscarinic receptor antagonists failed to enhance basel overflow. In contrast, when ChE activity was inhibited by 10(-6) M tacrine or pretreatment with 10(-4) M DFP, the ACh overflow was partially Ca(2+)-dependent and was reduced by tetrodotoxine. Moreover, block of the inhibitory muscarinic autoreceptors by (+/-)-telenzepine or pirenzepine caused a several-fold enhancement of the ACh release. The potencies of these antagonists were identical to those found for the electrically evoked [3H]-ACh release. The rate of ACh release enhanced by ChE inhibition plus telenzepine corresponds to about 12% of the total ACh pool per min, which is about the maximum amount of ACh that is available for any kind of stimuli. The release was dependent on the presence of exogenous choline. Hence elevation of ACh release led to a correspondingly enhanced ACh synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436122     DOI: 10.1007/BF00171077

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

Review 1.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

2.  Different muscarinic receptors mediate autoinhibition of acetylcholine release and vagally-induced vasoconstriction in the rat isolated perfused heart.

Authors:  I T Bognar; B Beinhauer; P Kann; H Fuder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

3.  Differences in antagonist affinities at muscarinic receptors in chick and guinea-pig.

Authors:  L K Choo; F Mitchelson; P Napier
Journal:  J Auton Pharmacol       Date:  1988-09

4.  Effect of coronary perfusion rate on the hydrolysis of exogenous and endogenous acetylcholine in the isolated heart.

Authors:  H A Dieterich; K Löffelholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-01       Impact factor: 3.000

5.  Subtypes of muscarinic receptor on cholinergic nerves and atrial cells of chicken and guinea-pig hearts.

Authors:  D Jeck; R Lindmar; K Löffelholz; M Wanke
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

6.  Cloning and functional analysis of a gene encoding a novel muscarinic acetylcholine receptor expressed in chick heart and brain.

Authors:  K M Tietje; P S Goldman; N M Nathanson
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

7.  Cholinergic transmission in cat parasympathetic ganglia.

Authors:  J P Gallagher; W H Griffith; P Shinnick-Gallagher
Journal:  J Physiol       Date:  1982-11       Impact factor: 5.182

8.  Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexus.

Authors:  H Kilbinger; M Nafziger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

9.  Competitive and non-competitive antagonism exhibited by 'selective' antagonists at atrial and ileal muscarinic receptor subtypes.

Authors:  R M Eglen; R L Whiting
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

10.  Interaction of telenzepine with muscarinic receptors in mammalian sympathetic ganglia.

Authors:  M Galvan; R Boer; C Schudt
Journal:  Eur J Pharmacol       Date:  1989-08-11       Impact factor: 4.432

View more
  7 in total

1.  Neostigmine-induced bradycardia following recent vs remote cardiac transplantation in the same patient.

Authors:  S B Backman; R D Stein; F E Ralley; G S Fox
Journal:  Can J Anaesth       Date:  1996-04       Impact factor: 5.063

2.  Neostigmine decreases heart rate in heart transplant patients.

Authors:  S B Backman; G S Fox; R D Stein; F E Ralley
Journal:  Can J Anaesth       Date:  1996-04       Impact factor: 5.063

Review 3.  Atrio-ventricular Block Following Neostigmine-Glycopyrrolate Reversal in Non-heart Transplant Patients: Case Report.

Authors:  Njinkeng J Nkemngu; Joel N Tochie
Journal:  Anesth Prog       Date:  2018

4.  Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies.

Authors:  O E Brodde; U Konschak; K Becker; F Rüter; U Poller; J Jakubetz; J Radke; H R Zerkowski
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

5.  Different properties of the bradycardia produced by neostigmine and edrophonium in the cat.

Authors:  S B Backman; R D Stein; D W Blank; B Collier; C Polosa
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

6.  Subtype-selective blockade of cardiac muscarinic receptors inhibits vagal chronotropic responses in cats.

Authors:  Oleg E Osadchii
Journal:  Pflugers Arch       Date:  2007-09-25       Impact factor: 3.657

7.  Inhibitory and excitatory muscarinic receptors modulating the release of acetylcholine from the postganglionic parasympathetic neuron of the chicken heart.

Authors:  G Brehm; R Lindmar; K Löffelholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.